Acadia Pharmaceuticals Inc 10-K for FY2023
Acadia Pharmaceuticals Inc (ACAD)
10-K
2024-02-28
For: 2023-12-31
View Original
Added on
April 04, 2026
About this 10-K
Acadia Pharmaceuticals Inc filed this 10-K on February 28, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $726.44M
- up 40.4% from $517.24M a year earlier
- Net loss
- $61.29M
- compared with a net loss of $215.98M a year earlier
- Diluted EPS
- -$0.37
- compared with -$1.34 a year earlier